Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Mar. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,351 $ 7,396
Accounts receivable, net 2,487 2,407
Inventories, net 3,025 2,663
Prepaid expenses and other current assets 3,315 3,746
Current portion of deferred consideration, net of discount 215 218
Total current assets 12,393 16,430
Property and equipment, net 305 320
Operating lease, right of use assets 530 559
Deferred tax asset 957 829
Deferred consideration, net of discount, less current portion 539 630
Other assets 238 77
Total assets 14,962 18,845
Current liabilities:    
Accounts payable 1,074 1,641
Accrued expenses and other current liabilities 1,789 1,843
Deferred revenue 100 1,223
Deferred revenue Invekra 53 54
Current portion of debt-PPP 0 120
Short-term debt 229 688
Operating lease liabilities 282 250
Total current liabilities 3,527 5,819
Long-term deferred revenue Invekra 138 182
Long-term debt 15 0
Withholding tax payable 4,013 3,838
Operating lease liabilities, less current portion 248 309
Total liabilities 7,941 10,148
Commitments and Contingencies (Note 5)
Stockholders’ Equity    
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at September 30, 2022 and March 31, 2022, respectively, no shares issued and outstanding at September 30, 2022 and March 31, 2022, respectively 0 0
Common stock, $0.0001 par value; 24,000,000 shares authorized at September 30, 2022 and March 31, 2022, respectively, 3,102,972 and 3,100,937 shares issued and outstanding at September 30, 2022 and March 31, 2022, respectively (Note 7) 2 2
Additional paid-in capital 197,697 197,370
Accumulated deficit (186,267) (184,363)
Accumulated other comprehensive loss (4,411) (4,312)
Total stockholders’ equity 7,021 8,697
Total liabilities and stockholders’ equity $ 14,962 $ 18,845